The Paris Colon Cancer Congress 2026 (P3C) will take place on December 10–11, 2026, in Paris, France.

Organized by the Young Oncologist in GI Group – Europe, part of the OncoDaily ecosystem, the international congress will bring together colorectal cancer specialists, multidisciplinary care teams, researchers, healthcare professionals, patient advocates, and international leaders to discuss the latest developments and challenges in colorectal cancer care.

The programme will explore early-onset, localized, and metastatic colorectal cancer, with discussions covering immunotherapy, biomarkers, treatment sequencing, survivorship, quality of life, and multidisciplinary decision-making. P3C will provide a platform for experts and patients to exchange perspectives, debate challenging clinical questions, and explore approaches to improving access, communication, and outcomes in colorectal cancer worldwide.

The congress is also accepting research abstracts and clinical case submissions, offering participants the opportunity to present their work to an international oncology audience. Selected high-scoring applicants will be considered for a P3C Merit Travel Grant, while accepted abstracts will be published in the OncoDaily Medical Journal.